Advanced Therapy Medicinal Product

Pic:getty/dani3315

Special Edition: Reviewing the advanced therapy pipeline

Atara Biotherapeutics: Developing an off-the-shelf therapy for MS with EBV T-cells

By Rachel Arthur

Atara Biotherapeutics is working on harnessing Epstein-Barr Virus (EBV) T-cells to help develop a new therapy for multiple sclerosis: saying the first-of-its-kind T-cell immunotherapy could not only slow decline but also help patients regain function...

© GettyImages/wildpixel

Report extols virtues of UK for the clinical development of ATMPs

By Jane Byrne

The number of advanced therapy medicinal product (ATMP) clinical trials in the UK continues to increase year on year with 154 ongoing trials observed in 2020, demonstrating the appeal of that market for the clinical development of ATMPs, shows a new report.

Spotlight

Follow us

Products

View more

Webinars

Featured Suppliers

All suppliers